JP2022519796A5 - - Google Patents
Info
- Publication number
- JP2022519796A5 JP2022519796A5 JP2021523466A JP2021523466A JP2022519796A5 JP 2022519796 A5 JP2022519796 A5 JP 2022519796A5 JP 2021523466 A JP2021523466 A JP 2021523466A JP 2021523466 A JP2021523466 A JP 2021523466A JP 2022519796 A5 JP2022519796 A5 JP 2022519796A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- antibody
- amino acid
- acid sequence
- concentration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811283440.7 | 2018-10-31 | ||
| CN201811283440.7A CN111110841A (zh) | 2018-10-31 | 2018-10-31 | 含有抗pcsk9抗体的稳定制剂 |
| PCT/CN2019/114233 WO2020088492A1 (zh) | 2018-10-31 | 2019-10-30 | 含有抗pcsk9抗体的稳定制剂 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022519796A JP2022519796A (ja) | 2022-03-25 |
| JP2022519796A5 true JP2022519796A5 (https=) | 2022-10-24 |
| JP7502286B2 JP7502286B2 (ja) | 2024-06-18 |
Family
ID=70464340
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021523466A Active JP7502286B2 (ja) | 2018-10-31 | 2019-10-30 | 抗ｐｃｓｋ９抗体を含む安定製剤 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20210393777A1 (https=) |
| EP (1) | EP3878467A4 (https=) |
| JP (1) | JP7502286B2 (https=) |
| KR (1) | KR20210096105A (https=) |
| CN (3) | CN111110841A (https=) |
| WO (1) | WO2020088492A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116261448A (zh) * | 2020-08-19 | 2023-06-13 | 百奥泰生物制药股份有限公司 | 用于治疗il-6相关疾病的包含高浓度人源化抗体的液体制剂 |
| CN114344460B (zh) * | 2020-10-13 | 2025-09-19 | 信立泰(成都)生物技术有限公司 | 含有抗pcsk9抗体的稳定制剂及其制备方法和用途 |
| JP2025522576A (ja) * | 2022-06-30 | 2025-07-15 | エーディー ファーマシューティカルズ カンパニー，リミティド | 抗ｐｃｓｋ９抗体製剤及びその応用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6629949B1 (en) | 2000-05-08 | 2003-10-07 | Sterling Medivations, Inc. | Micro infusion drug delivery device |
| US6659982B2 (en) | 2000-05-08 | 2003-12-09 | Sterling Medivations, Inc. | Micro infusion drug delivery device |
| JO3672B1 (ar) * | 2008-12-15 | 2020-08-27 | Regeneron Pharma | أجسام مضادة بشرية عالية التفاعل الكيماوي بالنسبة لإنزيم سبتيليسين كنفرتيز بروبروتين / كيكسين نوع 9 (pcsk9). |
| EP2501408B1 (en) * | 2009-11-20 | 2020-05-27 | Biocon Limited | Formulations of antibody |
| EP3409289B1 (en) * | 2010-02-26 | 2020-09-30 | Novo Nordisk A/S | Stable antibody containing compositions |
| AR087305A1 (es) * | 2011-07-28 | 2014-03-12 | Regeneron Pharma | Formulaciones estabilizadas que contienen anticuerpos anti-pcsk9, metodo de preparacion y kit |
| EA039663B1 (ru) * | 2012-05-03 | 2022-02-24 | Амген Инк. | Применение антитела против pcsk9 для снижения сывороточного холестерина лпнп и лечения связанных с холестерином расстройств |
| MX2018003298A (es) * | 2015-09-22 | 2018-06-20 | Pfizer | Metodo para preparar una formulacion de proteinas terapeuticas y formulacion de anticuerpos producida por tal metodo. |
| CN106810609A (zh) * | 2015-11-27 | 2017-06-09 | 苏州君盟生物医药科技有限公司 | 抗pcsk9抗体及其应用 |
-
2018
- 2018-10-31 CN CN201811283440.7A patent/CN111110841A/zh active Pending
-
2019
- 2019-10-30 US US17/290,078 patent/US20210393777A1/en not_active Abandoned
- 2019-10-30 EP EP19878080.1A patent/EP3878467A4/en not_active Withdrawn
- 2019-10-30 KR KR1020217016186A patent/KR20210096105A/ko not_active Withdrawn
- 2019-10-30 CN CN201980071607.XA patent/CN112955180A/zh active Pending
- 2019-10-30 WO PCT/CN2019/114233 patent/WO2020088492A1/zh not_active Ceased
- 2019-10-30 CN CN202511285329.1A patent/CN121130072A/zh active Pending
- 2019-10-30 JP JP2021523466A patent/JP7502286B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020518599A5 (https=) | ||
| RU2722643C2 (ru) | Способ лечения болезней глаз | |
| JP2017536414A5 (https=) | ||
| JP2020138981A5 (https=) | ||
| JP2023515271A5 (https=) | ||
| JP2015526440A5 (https=) | ||
| RU2012131099A (ru) | Препарат антитела | |
| JP2017160208A5 (https=) | ||
| JP2022532927A5 (https=) | ||
| JP2013543505A5 (https=) | ||
| JP2013500947A5 (https=) | ||
| RU2006120950A (ru) | Антитело к cd40: препарат и способы | |
| JP6250646B2 (ja) | 生物学的治療薬およびグアニジンまたはグアニジン誘導体を含む水性医薬組成物、並びに該組成物を含む注射剤 | |
| JP2022519796A5 (https=) | ||
| RU2015111341A (ru) | Композиции антитела и белка | |
| CN113797333A (zh) | 一种新型冠状病毒抗体的药物组合物及其用途 | |
| CN114762678B (zh) | 抗tigit抗体药物组合物及其用途 | |
| JP2020532562A5 (https=) | ||
| CL2024000232A1 (es) | Composición farmacéutica de anticuerpo anti-pd-1 y uso de la misma | |
| JP2025090691A5 (https=) | ||
| JP2024531151A5 (https=) | ||
| RU2020112302A (ru) | Соединения для уменьшения вязкости биологических композиций | |
| JP2023540025A5 (https=) | ||
| JP2024515968A5 (https=) | ||
| RU2018129077A (ru) | Стабильная фармацевтическая композиция |